We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Monoclonal Antibody Blocks Breast Cancer Metastasis in Mouse Model

By LabMedica International staff writers
Posted on 01 Jul 2013
Print article
Image: Metastasized human breast cancer cells (magnified 400 times, stained brown) in lymph nodes (Photo courtesy of the [US] National Cancer Institute).
Image: Metastasized human breast cancer cells (magnified 400 times, stained brown) in lymph nodes (Photo courtesy of the [US] National Cancer Institute).
A monoclonal antibody specific for the protein ROR1 (Receptor-tyrosine-kinase-like Orphan Receptor 1) was found to inhibit cell migration and invasion in cancer cell cultures and block tumor metastasis in a mouse breast cancel model.

Investigators at the University of California, San Diego (USA) had shown previously that ROR1, which is expressed during embryonic development and by various cancers, was not active in normal postpartum tissues. In the current study, which was published in the June 15, 2013, issue of the journal Cancer Research, the investigators linked expression of ROR1 to the process of epithelial-mesenchymal transition (EMT). EMT is a process by which epithelial cells lose their cell polarity and cell-cell adhesion, and gain migratory and invasive properties to become mesenchymal cells. EMT is essential for numerous developmental processes including mesoderm formation and neural tube formation. EMT has also been shown to occur in wound healing, in organ fibrosis, and in the initiation of metastasis for cancer progression.

The investigators found that breast adenocarcinomas expressing high levels of ROR1 were more likely to have gene expression signatures associated with EMT and had higher rates of relapse and metastasis than breast adenocarcinomas expressing low levels of ROR1. Suppressing expression of ROR1 in metastasis-prone breast cancer cell lines attenuated expression of proteins associated with EMT and impaired their capacity for migration and invasion in vitro and for metastasis in immunodeficient mice.

Treatment of a mouse breast-cancer model with a monoclonal antibody specific for ROR1 induced down modulation of EMT-promoting proteins and inhibited cancer cell migration and invasion in vitro and tumor metastasis in vivo. The investigators concluded that this finding indicated that antibodies targeting ROR1 could inhibit cancer progression and metastasis.

“We might think of ROR1 as an oncogene,” said first author Dr. Bing Cui, a postdoctoral researcher at the University of California, San Diego. “This means ROR1 has some tumor initiation functions. However, ROR1 also appears to allow transformed cells to invade other tissues and to promote tumor expansion in both the primary tumor site and in distant organs.”

Related Links:
University of California, San Diego

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.